Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Standards & Regulation

Business & Regulation Supply Chain

The Value of Dogged Determination

| Banks Bourne

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

Business & Regulation Business Practice

Teva Takes Hit in New York Opioid Case

| Stephanie Sutton

After other defendants in the case settle, Teva is left to face the music in New York alone.

Business & Regulation Biosimilars

ICER Report Exposes Humira Price Hikes

| Angus Stewart

A new report has exposed a Humira US price hike that dwarfs the rises in the price of other drugs.

Business & Regulation Advanced Medicine

2021 in Review: Our Best Videos

| Angus Stewart

Panels, thought leaders, and spicy opinions! Here’s a roundup of our best video content of 2021.

Business & Regulation Digital Technologies

Why We Need Patient-Centric Pharmacovigilance

| Saba Darvesh

Can digital approaches help improve pharmacovigilance practices?

Business & Regulation Standards & Regulation

The Sacred Texts

| Sue Batchelor

New ICH guideline revisions are imminent. Sue Batchelor of Cmed shares her thoughts on how sponsors and CROs can prepare themselves.

Business & Regulation Technology and Equipment

FDA Authorizes VR for Pain Reduction

| Stephanie Sutton

AppliedVR gets FDA OK to market virtual reality system for chronic pain.

Business & Regulation Standards & Regulation

Will it Really Be Built Back Better?

| Stephanie Sutton

A quick look at reactions across the US to Biden’s Build Back Better bill.

Business & Regulation COVID-19

R&R for an Anti-COVID Europe

| Angus Stewart

The EMA has given the nod to Ronapreve and Regkirona, two monoclonal antibody treatments for COVID-19.

Business & Regulation Standards & Regulation

Lobby and Legislature Play Pricing Plan Ping Pong

| Angus Stewart

After a madcap back and forth between leading and dissenting Democrats, Biden’s drug pricing reform plans have reached a compromised final form.


Latest White Papers

Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

LC-MS/MS method for the quantification of 10 nitrosamine impurities in metformin

| Contributed by Thermo Fisher Scientific

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register